Skip to main content

How the Darknet Is Disrupting the Drug Business

Drugs and the Darknet: Challenges and Opportunities (January 25, 2018)

Darknet markets, or “cryptomarkets,” are changing the way that people buy, sell, use, and make drugs around the world. These anonymous online markets are democratizing access to global drug supply chains, introducing new challenges and opportunities for supporting the health of people who use the products that flow through them.

In this panel discussion, Michael Gilbert, a public health technologist, and Nabarun Dasgupta, an epidemiologist studying the use of prescription opioids and heroin, discussed technologies, practices, opportunities, and challenges emerging from cryptomarkets.

The two presented a framework for understanding the role of cryptomarkets in global drug supply chains and how principles of harm reduction manifest in discourse and practice within them.

Listen to the event above.

Read more

Subscribe to updates about Open Society’s work around the world